Skip to content

Clinical trials

Completed Phase 3 Respiratory Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Status: Completed Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20061
20081
20094
20112
20123
20133
20146
20153
20163
20176
20182
20192
20204
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca16
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Medicago3
National Center for Research Resources (NCRR)3
AO GENERIUM2
Assistance Publique - Hôpitaux de Paris2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases53
Lung Diseases26
Lung Diseases, Obstructive17
Bronchial Diseases15
Asthma14
Respiratory Tract Infections9
Virus Diseases9
RNA Virus Infections6
Cystic Fibrosis5
Infections5

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.